Universities, research institutions, scientific organizations and regional authorities in the Science Region of Bonn have now all joined the current debate on xenophobia in Germany with a common appeal. The presidents, deans, directors, mayor and district…

In cooperation with colleagues in Munich and Göttingen, researchers at the DZNE in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat Alzheimers and other brain diseases.

DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.

Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and memory problems in mice.

A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize beta-amyloid – a finding that has implications for ongoing clinical…

The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by Knut. Knut is the first wild or domestic animal in which this…

British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the DZNE herewith honor his seminal contributions to the study of Alzheimer’s disease.

Professor Christian Haass, site speaker at the DZNE in Munich, yesterday has been honored by MetLife Foundation in the USA at the Alzheimer’s Association International Conference in Washington DC. Haass, also director of the Adolf Butenandt Institute (chair of…

The number of people in Germany who require nursing care has been rising steadily for years. Demographic developments indicate that this trend will continue. A parallel increase in the number of dementia patients is also being observed. These are important…

Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. Researchers of the DZNE draw this…